These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12453321)

  • 21. Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
    Punt CJ
    Ann Oncol; 2005 Jun; 16(6):845-6. PubMed ID: 15890668
    [No Abstract]   [Full Text] [Related]  

  • 22. Colorectal cancer: to stack or sequence therapy?
    Azvolinsky A
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25957442
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapy of colorectal carcinoma].
    Lutz MP; Adler G
    Internist (Berl); 2001 Dec; 42(12):1567-8, 1571-6, 1578-82. PubMed ID: 11793596
    [No Abstract]   [Full Text] [Related]  

  • 24. Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis.
    Masi G; Vasile E; Loupakis F; Cupini S; Fornaro L; Baldi G; Salvatore L; Cremolini C; Stasi I; Brunetti I; Fabbri MA; Puglisi M; Trenta P; Granetto C; Chiara S; Fioretto L; Allegrini G; Crinò L; Andreuccetti M; Falcone A
    J Natl Cancer Inst; 2011 Jan; 103(1):21-30. PubMed ID: 21123833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer.
    Nakayama G; Tanaka C; Uehara K; Mashita N; Hayashi N; Kobayashi D; Kanda M; Yamada S; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Ando Y; Kodera Y
    Cancer Chemother Pharmacol; 2014 Apr; 73(4):847-55. PubMed ID: 24577566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Controversy of treatment for advanced colorectal cancer--intermedisine].
    Sato A; Shimada K; Taguchi S
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1260-9. PubMed ID: 14518404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer.
    Comella P; Massidda B; Palmeri S; Putzu C; De Rosa V; Izzo F; Fiore F; Casaretti R; Sandomenico C
    Anticancer Drugs; 2006 Sep; 17(8):985-92. PubMed ID: 16940809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications and effect on survival of standard chemotherapy in advanced colorectal cancer.
    Kallinowski B
    Recent Results Cancer Res; 2005; 165():245-9. PubMed ID: 15865040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [5-fluorouracil and leucovorin therapy for advanced colorectal cancer].
    Shimoyama S; Kondo K; Kataoka M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():356-9. PubMed ID: 14574912
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer.
    Kono T; Ebisawa Y; Tomita I; Chisato N; Kamiya K; Asama T; Ayabe T; Ashida T; Kohgo Y; Kasai S
    J Chemother; 2005 Apr; 17(2):224-7. PubMed ID: 15920910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer.
    Moosmann N; Heinemann V
    Clin Colorectal Cancer; 2008 Mar; 7(2):110-7. PubMed ID: 18501070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.
    Grothey A; Hedrick EE; Mass RD; Sarkar S; Suzuki S; Ramanathan RK; Hurwitz HI; Goldberg RM; Sargent DJ
    J Clin Oncol; 2008 Jan; 26(2):183-9. PubMed ID: 18182660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens.
    Kline CL; Schiccitano A; Zhu J; Beachler C; Sheikh H; Harvey HA; Mackley HB; McKenna K; Staveley-O'Carroll K; Poritz L; Messaris E; Stewart D; Sivik J; El-Deiry WS
    Clin Colorectal Cancer; 2014 Jun; 13(2):119-26. PubMed ID: 24461492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.
    Sanoff HK; Sargent DJ; Campbell ME; Morton RF; Fuchs CS; Ramanathan RK; Williamson SK; Findlay BP; Pitot HC; Goldberg RM
    J Clin Oncol; 2008 Dec; 26(35):5721-7. PubMed ID: 19001325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.
    Dohn LH; Jensen BV; Larsen FO
    Acta Oncol; 2010 Apr; 49(3):395-6. PubMed ID: 20001495
    [No Abstract]   [Full Text] [Related]  

  • 37. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.
    Rothenberg ML; Oza AM; Bigelow RH; Berlin JD; Marshall JL; Ramanathan RK; Hart LL; Gupta S; Garay CA; Burger BG; Le Bail N; Haller DG
    J Clin Oncol; 2003 Jun; 21(11):2059-69. PubMed ID: 12775730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irinotecan in 5-fluorouracil-refractory colorectal cancer.
    Danesi R; Di Paolo A
    Clin Colorectal Cancer; 2002 Aug; 2(2):102-3. PubMed ID: 12453324
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolution of systemic therapy for metastatic colorectal cancer.
    Geh JI; Ma YT
    Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349
    [No Abstract]   [Full Text] [Related]  

  • 40. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Erlichman C; Goldberg RM; O'Connell MJ
    N Engl J Med; 2001 Jan; 344(4):305; author reply 306-7. PubMed ID: 11191661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.